You are here: Industry Insights > COVID-19

News List

Pharma firms initiate steps to curb black marketing of remedisivir expresspharma
July 09, 2020
Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with healthcare practitioners and regulators.
Cipla launches Cipremi, likely to price it Rs 4,000 per vial expresspharma
July 09, 2020
Cipla has launched its generic version of broad-spectrum anti-viral drug remdesivir (branded Cipremi), to treat severe infection of COVID-19.
Remdesivir can save more lives where ICUs are overwhelmed worldpharmanews
July 08, 2020
Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity ...
RedHill Receives Approval for COVID-19 Phase 2/3 Study with Opaganib in UK americanpharmaceuticalreview
July 08, 2020
RedHill Biopharma announced the UK Medicines & Healthcare products Regulatory Agency (MHRA) has approved the Company’s Clinical Trial Authorization (CTA) application to commence a Phase 2/3 study evaluating opaganib (Yeliva?, ABC294640) ...
SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization americanpharmaceuticalreview
July 08, 2020
Beckman Coulter announced its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA).
RevImmune Announces Phase II Trial of the T-Cell Growth Factor for COVID-19 americanpharmaceuticalreview
July 08, 2020
RevImmune has launched the "ILIAD" Phase II trial for treatment of COVID-19.Many COVID-19 clinical trials have focused on decreasing the hyper-inflammatory phase that often occurs in COVID-19 patients and can cause substantial damage.
Expanded access for compassionate use of remestemcel-L in COVID-19 infected children europeanpharmaceuticalreview
July 08, 2020
US expands access to remestemcel-L for compassionate use in COVID-19 infected children with complications of multisystem inflammatory syndrome.
Mylan gets approval for emergency use of remdesivir for Covid-19 pharmaceutical-technology
July 08, 2020
Mylan has secured regulatory approval from the Drug Controller General of India (DCGI) for restricted emergency use of 100mg/vial remdesivir lyophilized powder to treat Covid-19.
Inflammation key to severe COVID-19 in high-risk groups: Study expresspharma
July 08, 2020
A small study of high-risk COVID-19 patients may help explain why their health issues contribute to more severe cases of the illness. Chronic conditions like obesity, diabetes, liver disease, hypertension, and heart disease also cause inflammation.
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against COVID-19 expresspharma
July 08, 2020
It is to determine safety and efficacy of three combination drugs (Favipiravir+Colchicine, Umifenovir+Colchicine and Nafamostat+5-ALA) and a control arm with the standard of care in COVID-19 patients.